|
|
Becker, J.R., Robinson, T.Y., Sachidanandan, C., Kelly, A.E., Coy, S., Peterson, R.T., and MacRae, C.A. (2012) In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signaling. Cardiovascular research. 93(3):463-470
|
Chen, D., Zhang, Z., Chen, C., Yao, S., Yang, Q., Li, F., He, X., Ai, C., Wang, M., Guan, M.X. (2019) Deletion of Gtpbp3 in zebrafish revealed the hypertrophic cardiomyopathy manifested by aberrant mitochondrial tRNA metabolism. Nucleic acids research. 47(10):5341-5355
|
De Jong, H.N., Dewey, F.E., Cordero, P., Victorio, R.A., Kirillova, A., Huang, Y., Madhvani, R., Seo, K., Werdich, A.A., Lan, F., Orcholski, M., Robert Liu, W., Erbilgin, A., Wheeler, M.T., Chen, R., Pan, S., Kim, Y.M., Bommakanti, K., Marcou, C.A., Martijn Bos, J., Haddad, F., Ackerman, M., Vasan, R.S., MacRae, C., Wu, J.C., de Jesus Perez, V., Snyder, M., Parikh, V.N., Ashley, E.A. (2022) Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy. Circulation. Genomic and precision medicine. 15(4):e003563
|
Hedberg-Oldfors, C., Abramsson, A., Osborn, D.P.S., Danielsson, O., Fazlinezhad, A., Nilipour, Y., Hübbert, L., Nennesmo, I., Visuttijai, K., Bharj, J., Petropoulou, E., Shoreim, A., Vona, B., Ahangari, N., López, M.D., Doosti, M., Banote, R.K., Maroofian, R., Edling, M., Taherpour, M., Zetterberg Md, H., Karimiani, E.G., Oldfors, A., Jamshidi, Y. (2019) Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24. Human molecular genetics. 28(11):1919-1929
|
Okamoto, R., Goto, I., Nishimura, Y., Kobayashi, I., Hashizume, R., Yoshida, Y., Ito, R., Kobayashi, Y., Nishikawa, M., Ali, Y., Saito, S., Tanaka, T., Sawa, Y., Ito, M., Dohi, K. (2020) Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish. PLoS One. 15:e0240129
|
Romano, D., Nguyen, L.K., Matallanas, D., Halasz, M., Doherty, C., Kholodenko, B.N., Kolch, W. (2014) Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling. Nature cell biology. 16:673-84
|
Sasagawa, S., Nishimura, Y., Okabe, S., Murakami, S., Ashikawa, Y., Yuge, M., Kawaguchi, K., Kawase, R., Okamoto, R., Ito, M., Tanaka, T. (2016) Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy. Frontiers in pharmacology. 7:162
|
Shi, X., Zhang, Y., Chen, R., Gong, Y., Zhang, M., Guan, R., Rotstein, O.D., Liu, X., Wen, X.Y. (2020) ndufa7 plays a critical role in cardiac hypertrophy. Journal of Cellular and Molecular Medicine. 24(22):13151-13162
|